Page last updated: 2024-10-22

ampiroxicam and Glomerulonephritis, Membranous

ampiroxicam has been researched along with Glomerulonephritis, Membranous in 1 studies

ampiroxicam: prodrug of piroxicam; structure given in first source
ampiroxicam : A benzothiazine that is the 1-[(ethoxycarbonyl)oxy]ethyl ether of piroxicam. A prodrug for piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis.

Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishimura, M1
Uzu, T1
Inenaga, T1
Kimura, G1

Other Studies

1 other study available for ampiroxicam and Glomerulonephritis, Membranous

ArticleYear
Membranous nephropathy induced by treatment with ampiroxicam, a nonsteroidal antiinflammatory drug.
    Nephron, 1999, Volume: 83, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Glomerulonephritis, Membranous; Humans; Male; Thiazin

1999